This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Innogenetics N.v.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Stany Depraetere: Innovator in HCV Envelope Proteins
Introduction
Stany Depraetere is a notable inventor based in Oudenaarde, Belgium. He has made significant contributions to the field of virology, particularly in the development of hepatitis C virus (HCV) envelope proteins. His innovative work has led to advancements in the understanding and treatment of HCV.
Latest Patents
Stany Depraetere holds a patent for "HCV E1 comprising specific disulfide bridges." This invention relates to recombinantly or synthetically produced HCV E1 envelope proteins or parts thereof that include disulfides between specific cysteine residues. The patent also covers viral-like particles and compositions that incorporate these HCV E1 envelope proteins, as well as methods and kits utilizing these proteins.
Career Highlights
Stany Depraetere is associated with Innogenetics N.V., a company known for its focus on innovative solutions in the field of molecular diagnostics and therapeutic development. His work at Innogenetics has been pivotal in advancing research related to HCV.
Collaborations
Throughout his career, Stany has collaborated with notable colleagues such as Erik Depla and Gert Verheyden. These collaborations have contributed to the success of his research and the development of his patented technologies.
Conclusion
Stany Depraetere's contributions to the field of virology, particularly through his patent on HCV E1 envelope proteins, highlight his role as an innovator in medical research. His work continues to influence the understanding and treatment of hepatitis C.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile